Contract manufacturing organizations (CMOs) need the flexibility to respond to ever-evolving client needs. Likewise, manufacturers who are bringing their ATMP production activities in-house have complex product pipelines and need the flexibility to develop different modalities in parallel, unsure of which will ultimately go to market. Both are united by the same challenge: they need a facility that can accommodate a pipeline of four or five product types, each requiring a highly sensitive process.
But designing a bespoke production suite unique to each modality would lead to astronomical costs and a sprawling, inefficient facility. Why not fight cancer with an mAb product? Fight a pandemic with a vaccine platform? Do it all in the same manufacturing suite, weeks apart. Hypersonic speed-to-market, powered by a new breed of highly responsive multi-modal facility design is upon us.
Attendees will learn: